2024. FOSTAMATINIB AS A NOVEL THERAPEUTIC APPROACH FOR REFRACTORY IMMUNE THROMBOCYTOPENIA IN AN HIV-POSITIVE PATIENT: A CASE REPORT. European Journal of Emerging Clinical Case Reports. 1, 01 (Dec. 2024), 39–45.